Replies to post #212411 on Biotech Values

[DewDiligence]

…[CAR-T]…treatment for children with a lifetime ahead of them has more chance to be cost-effective…

However, one must factor in the cost of IVIG, as mentioned in #msg-132940006.

Then again, MNTA’s M254 (#msg-132953972) may make it to market!